Literature DB >> 19090721

Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran.

Farahnoosh Doustdar1, Azar Dokht Khosravi, Parissa Farnia, Mohammad Reza Masjedi, Ali Akbar Velayati.   

Abstract

Considering the significant increase of isoniazid (INH) resistance in Iranian Mycobacterium tuberculosis isolates in the last few years and to investigate the prevalence and diagnostic potential of the most commonly reported mutations associated with INH resistance in Iran, we analyzed parts of the katG gene and fabG1-inhA and oxyR-ahpC regulatory regions in a sample of 48 INH-resistant and 25 INH-sensitive isolates. Mutations in the katG 315, fabG1-inhA, and oxyR-ahpC regulatory regions were detected in 58.3%, 18.7%, and 39.6% of isolates, respectively. The R463L polymorphism in the katG gene and the ahpC46A were detected with high frequency in both INH-resistant and -sensitive isolates. Spoligotyping and IS6110-based restriction fragment length polymorphism patterns revealed that most of the isolates containing ahpC46A and katG 463Leu polymorphism belonged to the Central Asian (CAS) super family. The tight relationship between ahpC46A and katG 463Leu polymorphisms and the CAS super family highlights the importance of the CAS super family in INH resistance in Iran. In conclusion, mutations at katG codon 315 or the fabG1-inhA regulatory region were identified in 77.0% of the INH-resistant isolates and in none of the INH-sensitive strains, and are highly predictive of isonizid resistance in Iranian isolates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19090721     DOI: 10.1089/mdr.2008.0842

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

1.  An effective nano drug delivery and combination therapy for the treatment of Tuberculosis.

Authors:  Mojgan Sheikhpour; Vincent Delorme; Alibakhsh Kasaeian; Vahid Amiri; Morteza Masoumi; Mohammad Sadeghinia; Nayereh Ebrahimzadeh; Mobina Maleki; Shahin Pourazar
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

2.  Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran.

Authors:  Noormohamad Mansoori; Farzam Vaziri; Sirus Amini; Sharareh Khanipour; Shahin Pourazar Dizaji; Masoumeh Douraghi
Journal:  Infect Drug Resist       Date:  2020-07-01       Impact factor: 4.003

3.  Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.

Authors:  Christine E Cade; Adrienne C Dlouhy; Katalin F Medzihradszky; Saida Patricia Salas-Castillo; Reza A Ghiladi
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

4.  Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis.

Authors:  Danny C T Ong; Wing-Cheong Yam; Gilman K H Siu; Ann S G Lee
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

5.  Mycobacterial interspersed repetitive unit typing in Mycobacterium tuberculosis isolates from Sichuan province in China.

Authors:  Jian-Hua Guo; Wen-Liang Xiang; Geng Zhang; Tao Luo; Ning Xie; Zhi-Rong Yang; Qun Sun
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

6.  Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates.

Authors:  Guilian Li; Jingrui Zhang; Qian Guo; Yi Jiang; Jianhao Wei; Li-li Zhao; Xiuqin Zhao; Jianxin Lu; Kanglin Wan
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

7.  Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates.

Authors:  Ashok Singh Charan; Neeraj Gupta; Ramakant Dixit; Piyush Arora; Tarun Patni; Kalliath Antony; Manisha Singh
Journal:  Lung India       Date:  2020 May-Jun

Review 8.  Prevalence and occurrence rate of Mycobacterium tuberculosis Haarlem family multi-drug resistant in the worldwide population: A systematic review and meta-analysis.

Authors:  Rashid Ramazanzadeh; Daem Roshani; Pegah Shakib; Samaneh Rouhi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.